{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0007743,73,MONDO:0007743,175,-1]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0007743","source":"MONDO:0007743|attention deficit-hyperactivity disorder","targets":["NCT00152750|Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00181571|A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder|COMPLETED|PHASE4|INTERVENTIONAL","NCT00181675|A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder|COMPLETED|PHASE4|INTERVENTIONAL","NCT00181714|Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta|COMPLETED|PHASE4|INTERVENTIONAL","NCT00181948|Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00181987|Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder|COMPLETED|PHASE4|INTERVENTIONAL","NCT00190736|Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00190775|A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00190879|Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder|COMPLETED|PHASE4|INTERVENTIONAL","NCT00190957|Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse|COMPLETED|PHASE4|INTERVENTIONAL","NCT00191906|Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00216918|Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.|COMPLETED|PHASE4|INTERVENTIONAL","NCT00221962|Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00223561|Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder|COMPLETED|PHASE4|INTERVENTIONAL","NCT00299234|Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL|TERMINATED|PHASE4|INTERVENTIONAL","NCT00302406|Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate|COMPLETED|PHASE4|INTERVENTIONAL","NCT00305370|Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00381758|The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting|COMPLETED|PHASE4|INTERVENTIONAL","NCT00406354|Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany|COMPLETED|PHASE4|INTERVENTIONAL","NCT00434213|Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA|COMPLETED|PHASE4|INTERVENTIONAL","NCT00468143|A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall|COMPLETED|PHASE4|INTERVENTIONAL","NCT00471354|A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine|COMPLETED|PHASE4|INTERVENTIONAL","NCT00483106|Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00485849|A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00485875|Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00486122|Evaluation of Continuous Symptom Treatment of ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00500071|Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00506727|Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00510276|Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes|COMPLETED|PHASE4|INTERVENTIONAL","NCT00517504|Methylphenidate Study in Young Children With Developmental Disorders|COMPLETED|PHASE4|INTERVENTIONAL","NCT00517647|Atomoxetine Pilot Study in Preschool Children With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00518232|A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder|COMPLETED|PHASE4|INTERVENTIONAL","NCT00530257|Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory|COMPLETED|PHASE4|INTERVENTIONAL","NCT00536419|Impact of Attention Deficit/Hyperactivity Disorder and Substance Use Disorder on Motorcycle Traffic Accidents|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00546910|Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00552266|Methylphenidate in ADHD With Trichotillomania|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00564954|A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00566371|The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents|COMPLETED|PHASE4|INTERVENTIONAL","NCT00573534|Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse|COMPLETED|PHASE4|INTERVENTIONAL","NCT00585910|Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00586157|Study of Medication Patch to Treat Children Ages 6-12 With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00586573|Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT00593112|Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate|COMPLETED|PHASE4|INTERVENTIONAL","NCT00607919|Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia|COMPLETED|PHASE4|INTERVENTIONAL","NCT00663442|Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00687609|Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE|TERMINATED|PHASE4|INTERVENTIONAL","NCT00716274|Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia|COMPLETED|PHASE4|INTERVENTIONAL","NCT00733356|The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading|COMPLETED|PHASE4|INTERVENTIONAL","NCT00753012|Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults|COMPLETED|PHASE4|INTERVENTIONAL","NCT00754208|Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children|COMPLETED|PHASE4|INTERVENTIONAL","NCT00760747|Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00770627|Clinical Trial to Evaluate the Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00783835|Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00799409|Lab School Day Study for CONCERTA of Older Children With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00799487|CONCERTA Lab School Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT00801229|Effect of Vyvanse on Driving in Young Adults With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00842127|Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00844753|Atomoxetine, Placebo and Parent Management Training in Autism|COMPLETED|PHASE4|INTERVENTIONAL","NCT00852059|Adherence to Stimulant Treatment in Attention-Deficit Hyperactivity Disorder (ADHD) Patients (ASTA)|TERMINATED|PHASE4|INTERVENTIONAL","NCT00856063|Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00862108|Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00863499|International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00866996|Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder|COMPLETED|PHASE4|INTERVENTIONAL","NCT00907218|Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)|TERMINATED|PHASE4|INTERVENTIONAL","NCT00918567|Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00936299|Bupropion for ADHD in Adolescents With Substance Use Disorder|COMPLETED|PHASE4|INTERVENTIONAL","NCT00938743|Driving in Adults With Attention-deficit/Hyperactivity Disorder (ADHD) Before and During Treatment With Atomoxetine|COMPLETED|PHASE4|INTERVENTIONAL","NCT01017263|Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity|TERMINATED|PHASE4|INTERVENTIONAL","NCT01063153|Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials|COMPLETED|PHASE4|INTERVENTIONAL","NCT01065259|Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children|COMPLETED|PHASE4|INTERVENTIONAL","NCT01070394|Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01127607|Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?|COMPLETED|PHASE4|INTERVENTIONAL","NCT01127646|A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents|TERMINATED|PHASE4|INTERVENTIONAL","NCT01133847|Interventions for Children With Attention and Reading Disorders|COMPLETED|PHASE4|INTERVENTIONAL","NCT01143701|Evaluation of an Intervention for Improving Community-based Pediatric Attention-Deficit Hyperactivity Disorder (ADHD) Care|COMPLETED|PHASE4|INTERVENTIONAL","NCT01177306|Inuniv and Working Memory|COMPLETED|PHASE4|INTERVENTIONAL","NCT01207622|Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT01220440|Comparing the Efficacy of Methylphenidate, Dextroamphetamine and Placebo in Children Diagnosed With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT01238822|Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01328756|Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01339286|Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01365897|Effectiveness of Modafinil in Improving Cognitive Performance of University Students|COMPLETED|PHASE4|INTERVENTIONAL","NCT01393574|Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01439126|Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder|COMPLETED|PHASE4|INTERVENTIONAL","NCT01673594|Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist|COMPLETED|PHASE4|INTERVENTIONAL","NCT01678209|Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach|COMPLETED|PHASE4|INTERVENTIONAL","NCT01709695|Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT01721330|A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder|TERMINATED|PHASE4|INTERVENTIONAL","NCT01764672|Effect of Methylphenidate on Connectivity|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT01778647|Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD|TERMINATED|PHASE4|INTERVENTIONAL","NCT01816074|Sequencing Treatments for Mothers With ADHD and Their At - Risk Children|COMPLETED|PHASE4|INTERVENTIONAL","NCT01831622|Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder|COMPLETED|PHASE4|INTERVENTIONAL","NCT01858064|Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT01873729|An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.|COMPLETED|PHASE4|INTERVENTIONAL","NCT01924429|Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation|COMPLETED|PHASE4|INTERVENTIONAL","NCT01933217|Methylphenidate for Attention Problems After Pediatric TBI|COMPLETED|PHASE4|INTERVENTIONAL","NCT01933880|A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants|COMPLETED|PHASE4|INTERVENTIONAL","NCT01940978|A Study of Combination Therapy in Children With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT01985581|Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD|COMPLETED|PHASE4|INTERVENTIONAL","NCT01986062|Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting|COMPLETED|PHASE4|INTERVENTIONAL"]}]}